Copyright
©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4285-4291
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4285
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4285
Parameter | Recorded value | Standard value |
White blood cell count | 4800/µL | 4500-7500/µL |
Lymphocyte count | 1300/µL | |
Red blood cell count | 327 × 103/µL | 380-480 × 103/µL |
Hemoglobin | 9.4 g/dL | 11.3-15.2 g/dL |
Hematocrit | 31.3% | 36%-45% |
Platelet count | 10.6 × 103/µL | 13-35 × 103/µL |
International normalized ratio | 1.05 | 0.80-1.20 |
Activated partial thromboplastin time | 34.5 s | 26.9-38.1 s |
Fibrinogen | 374 mg/L | 150-400 mg/dL |
D-dimer | 6.9 µg/mL | ≤ 1.0 µg/mL |
C-reactive protein | 9.51 mg/L | ≤ 1.0 mg/L |
Total protein | 7.5 g/dL | 6.9-8.4 g/dL |
Albumin | 3.6 g/dL | 3.9-5.1 g/dL |
Total bilirubin | 0.6 mg/dL | 0.2-1.2 mg/dL |
Aspartate aminotransferase | 22 U/L | 11-30 U/L |
Alanine aminotransferase | 24 U/L | 4-30 U/L |
Lactate dehydrogenase | 262 U/L | 109-216 U/L |
Creatine phosphokinase | 75 U/L | 40-150 U/L |
Blood urea nitrogen | 7.6 mg/dL | 8-20 mg/dL |
Creatinine | 0.43 mg/dL | 0.63-1.03 mg/dL |
Sodium | 137 mEq/L | 136-148 mEq/L |
Potassium | 3.6 mEq/L | 3.6-5.0 mEq/L |
Chloride | 103 mEq/L | 98-108 mEq/L |
Glucose | 146 mg/dL | 70-109 mg/dL |
Hemoglobin A1c | 5.7% | ≤ 5.8% |
- Citation: Kamada M, Kenzaka T. Successful treatment of warfarin-induced skin necrosis using oral rivaroxaban: A case report. World J Clin Cases 2019; 7(24): 4285-4291
- URL: https://www.wjgnet.com/2307-8960/full/v7/i24/4285.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i24.4285